CoChat

Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53

Turenne, Gaetan A, Paul, Proma, Laflair, Lareina, Price, Brendan D · 2001 · Oncogene

The DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.

Abstract

The ATM protein kinase regulates the cell's response to DNA damage by regulating cell cycle checkpoints and DNA repair. ATM phosphorylates several proteins involved in the DNA-damage response, including p53. We have examined the mechanism by which ATM regulates p53's transcriptional activity. Here, we demonstrate that reintroduction of ATM into AT cells restores the activation of p53 by the radio-mimetic agent bleomycin. Further, p53 activation is lost when a kinase inactive ATM is used, or if the N-terminal of ATM is deleted. In addition, AT cells stably expressing ATM showed decreased sensitivity to Ionizing Radiation-induced cell killing, whereas cells expressing kinase inactive ATM or N-terminally deleted ATM were indistinguishable from AT cells. Finally, single point-mutations of serines 15, 20, 33 or 37 did not individually block the ATM-dependent activation of p53 transcriptional activity by bleomycin. However, double mutations of either serines 15 and 20 or serines 33 and 37 blocked the ability of ATM to activate p53. Our results indicate that the N-terminal of ATM and ATM's kinase activity are required for activation of p53's transcriptional activity and restoration of normal sensitivity to DNA damage. In addition, activation of p53 by ATM requires multiple serine residues in p53's transactivation domain.

Overview

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1204665

Cites

58 of 58 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 58 references

Cited by

See all 125

Metadata

Authors
Turenne, G. A., Paul, P., Laflair, L., & Price, B. D.
Affiliations
Harvard University (US)
Corresponding author
Price, Brendan D
Venue
Oncogene
Published
2001-08-23
Volume
20
Issue
37
Pages
5100-5110
ISSN
  • 0950-9232 (ISSN-L)
  • 1476-5594
OpenAlex
W2098444271
Cited by
120
References
59
Citations by year
2026: 4 · 2025: 5 · 2024: 4 · 2023: 8 · 2022: 9 · 2021: 12 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 3 · 2015: 3 · 2014: 2 · 2013: 3 · 2012: 4
FWCI
3.10
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Oncogene (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (R01CA064585, CA64585)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Keywords
ATM kinase, p53, p53 transcriptional activation, transactivation domain, DNA damage response, bleomycin, radiosensitivity, cell cycle checkpoints
MeSH terms
Antimetabolites, Antineoplastic, Bleomycin, Cell Line, DNA Damage, Dose-Response Relationship, Drug, Dose-Response Relationship, Radiation, Enzyme Activation, Humans, Mutation, Phosphorylation, Precipitin Tests, Serine, Transcription, Genetic, Blotting, Western, Transcriptional Activation, Genes, p53, Tumor Suppressor Protein p53, Mutagenesis, Site-Directed, Protein Serine-Threonine Kinases, Gene Deletion, Protein Structure, Tertiary, Cell Cycle Proteins, Ataxia Telangiectasia Mutated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53. https://app.cochat.ai/papers/10.1038/sj.onc.1204665
The paper
Turenne, G. A., Paul, P., Laflair, L., & Price, B. D. (2001). Activation of p53 transcriptional activity requires ATM's kinase domain and multiple N-terminal serine residues of p53. Oncogene. https://doi.org/10.1038/sj.onc.1204665

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.